CD137+PD-1highCD8+ T cells exhibited higher levels of tumor reactivity and T cell activation markers, and were markedly enriched in T cell inflammatory genetic features, including active IFN-γ responses, cytotoxic effector functions and activated cytokines associated with anti-PD-1 treatment responses (92). The gene discussed is TNFRSF9; the disease is neoplasm.